Impact Biomedical (IBO) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
IMPACT BIOMEDICAL INC.  (NYSE: IBO)

Impact Biomedical's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Impact Biomedical in the third quarter 2026?
IMPACT BIOMEDICAL INC. achieved a return on average equity (ROE) of 11.14 % in its third quarter 2026, this is above IBO's average return on equity of -321.91%.
Impact Biomedical Inc. shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $14 million

ROE has advanced compared to 8.76% in the second quarter 2026, due to net income growth.

Within the Major Pharmaceutical Preparations industry IMPACT BIOMEDICAL INC. achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 3824 to 3832.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change - - 116.02 % 114.94 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 2 1 -13 -12 -44
Return On Equity (TTM) 11.14 % 8.76 % -367.02 % -774.3 % -
IBO's Total Ranking # 3832 # 3824 # # #
Equity (TTM) in Millions 13 14 15 16 -9
Seq. Equity Change -4.61 % -4.75 % -5.43 % - -
Seq. Net Income Change - - - - -

Back to IBO Management Effectiveness >> IBO's 5 Years Annual ROE >> Compare IBO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 0
Sector # 0
Overall # 3832

Return On Equity Statistics
High Average Low
9.56 %
-321.91 %
-1494.96 %
(Jun 30 2026)   (Dec 31 2025)





IBO Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2022)
2023

Total Equity in Millions 16 7 33 0 0
Y / Y Equity Change 114.94 % -77.85 % - - -
Net Income in Millions -12 -25 -7 0 0
Y / Y Net Income Change - - - - -
Return On Equity -76.31 % -342.27 % -21.58 % - -

Back to IBO Management Effectiveness >> IBO's 5 Years Annual ROE >> Compare IBO ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
IBO's' Return on Equity at Yahoo Finance
IBO's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for IBO's Competitors
Subscribers only: Roe for Impact Biomedical's Suppliers
Subscribers only: Return On Equity for IBO's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Transmedics Group Inc   28.74 %
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %
Ensign Group Inc  16.62 %
Lemaitre Vascular Inc   15.81 %
Stryker Corp  15.61 %

Date modified: 2026-11-10T10:03:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.